Skip to main content

Gender-Affirming Surgery — Overview

Gender-affirming surgery (GAS) encompasses procedures that align an individual's physical anatomy with their gender identity, broadly grouped into breast / chest surgery, genital reconstruction, and facial / body procedures.123 Major medical organizations including WPATH, the Endocrine Society, AMA, and ACOG support these surgeries as medically necessary interventions for appropriately selected patients.142

Detailed pages: Feminizing procedures, Masculinizing procedures, Revision & Salvage GAS, and Non-Binary & Nullification. For the cisgender congenital counterpart to feminizing reconstruction, see Müllerian Anomalies & Vaginal Agenesis.

Categories of Procedures​

Masculinizing (Transmasculine)23​

  • Top surgery — subcutaneous mastectomy with chest reconstruction; the most commonly performed transmasculine procedure (~93% of transgender men on hormones desire it).
  • Genital surgery — metoidioplasty (release of the hormonally enlarged clitoris to create a microphallus) or phalloplasty (creation of a neophallus using a tissue flap, often radial forearm); hysterectomy / oophorectomy; vaginectomy; scrotoplasty.
  • Other — voice surgery, liposuction, pectoral implants.

Feminizing (Transfeminine)23​

  • Breast augmentation — typically subglandular or subpectoral implants.
  • Genital surgery — vaginoplasty (penile inversion creating a vaginal vault, clitoris, and labia), orchiectomy, vulvoplasty.
  • Facial feminization surgery (FFS) — brow lift, rhinoplasty, mandible contouring, tracheal shave; often prioritized because it shapes public-facing appearance and personal safety.
  • Other — voice surgery, body contouring, hair reconstruction.

Eligibility Criteria​

The Endocrine Society guideline recommends the following for genital surgery affecting fertility:4

  1. Persistent, well-documented gender dysphoria.
  2. Legal age of majority (≥ 18 years).
  3. At least 12 months of consistent hormone therapy (if not contraindicated).
  4. 12 months of continuous living in the congruent gender role.
  5. Well-controlled medical and mental health conditions.
  6. Demonstrated knowledge of surgical aspects (costs, complications, rehabilitation).

Two independent mental health professional letters are required for genital surgery; one letter suffices for hormone therapy or breast / chest surgery.5 WPATH SOC 8 recommends at least 6 months of hormone therapy before most surgical interventions, with the exception of chest surgery in transmasculine patients.6

Outcomes and Safety​

GAS is generally safe with high satisfaction rates:

  • Overall complication rate — ~6% across all GAS procedures; 3.5% for top surgery, 8% for bottom surgery, and 2.1% for head / neck procedures in an NSQIP analysis of 4,114 patients.7
  • Vaginoplasty — Clavien-Dindo ≥ 3 complications in 5.5% of 488 cases, no 30-day mortality. Wound-related issues were the most common; higher BMI and ASA class were associated with increased complication risk.8
  • Phalloplasty — least commonly performed genital procedure due to higher morbidity (urethral strictures, donor-site scarring).3
  • Satisfaction and regret — regret rates are < 4%; detransition is rare. A 40-year follow-up demonstrated durable improvements in body congruency, mental health, and reduced suicidal ideation, with no reported patient regret.69
  • Mortality — directly related to GAS is "practically zero" across studies.5 Acute postoperative care of these patients in the hospital setting is reviewed in detail elsewhere.10

Despite this safety profile, 94% of patients report encountering at least one barrier to obtaining GAS — driven by insurance denials, geographic access, and surgeon-volume distribution.1

Postoperative Considerations​

Vaginoplasty patients require commitment to a dilation regimen (up to three times daily initially) to maintain vaginal depth and width. The neovagina is lined by skin rather than mucosa and does not self-lubricate. Patients with persistent pain during dilation may benefit from pelvic floor physical therapy.2 Long-term follow-up should monitor cardiovascular risk and mental health, both of which remain elevated compared with the general population even after surgery.5

Footnotes​

  1. Pletta DR, Quint M, Radix AE, et al. "Gender-Affirming Surgical History, Satisfaction, and Unmet Needs Among Transgender Adults." JAMA Netw Open. 2025;8(9):e2532494. doi:10.1001/jamanetworkopen.2025.32494 ↩ ↩2 ↩3

  2. Cronin B, Stockdale CK. "Health Care for Transgender and Gender Diverse Individuals." American College of Obstetricians and Gynecologists, 2021. ↩ ↩2 ↩3 ↩4 ↩5

  3. Safer JD, Tangpricha V. "Care of Transgender Persons." N Engl J Med. 2019;381(25):2451–2460. doi:10.1056/NEJMcp1903650 ↩ ↩2 ↩3 ↩4

  4. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. "Endocrine Treatment of Gender-Dysphoric / Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2017;102(11):3869–3903. doi:10.1210/jc.2017-01658 ↩ ↩2

  5. Wylie K, Knudson G, Khan SI, et al. "Serving Transgender People: Clinical Care Considerations and Service Delivery Models in Transgender Health." Lancet. 2016;388(10042):401–411. doi:10.1016/S0140-6736(16)00682-6 ↩ ↩2 ↩3

  6. Dakkak M, Kriegel DL II, Tauches K. "Caring for Transgender and Gender-Diverse People: Guidelines From WPATH." Am Fam Physician. 2023;108(6):626–629. ↩ ↩2

  7. Scott KB, Thuman J, Jain A, Gregoski M, Herrera F. "Gender-Affirming Surgeries: A National Surgical Quality Improvement Project Database Analyzing Demographics, Trends, and Outcomes." Ann Plast Surg. 2022;88(5 Suppl 5):S501–S507. doi:10.1097/SAP.0000000000003157 ↩

  8. Mishra K, Ferrando CA. "Postoperative Adverse Events Following Gender-Affirming Vaginoplasty: An American College of Surgeons National Surgical Quality Improvement Program Study." Am J Obstet Gynecol. 2023;228(5):564.e1–564.e8. doi:10.1016/j.ajog.2023.01.011 ↩

  9. Park RH, Liu YT, Samuel A, et al. "Long-Term Outcomes After Gender-Affirming Surgery: 40-Year Follow-Up Study." Ann Plast Surg. 2022;89(4):431–436. doi:10.1097/SAP.0000000000003233 ↩

  10. Rosendale N, Goldman S, Ortiz GM, Haber LA. "Acute Clinical Care for Transgender Patients: A Review." JAMA Intern Med. 2018;178(11):1535–1543. doi:10.1001/jamainternmed.2018.4179 ↩